28 reports

The same study also shows diabetes, high cholesterol, heart disease, high blood pressure, sleep apnea, asthma, cancer, depression and strokes to be linked to obesity drugs.

  • Obesity
  • Pathology
  • World
  • Forecast
  • 8.1.3 MEXICO

ASTHMA, COPD) FOR WHICH RESEARCH AND DEVELOPMENT IS LESS WELL-ADVANCED.

  • Obesity
  • United States
  • DuPont
  • Enterome Bioscience SA
  • Synlogic, Inc.

Jude Medical List of Exhibits ##: Executive Summary Table ##-##: The Global Market for Advanced Patient Monitoring Systems, 2012-2021 ##: Advanced Patient Monitoring Products and Technologies Table ##-##: Clinical Trial Activity by Industry Participant Figure ##-

  • Obesity
  • Patient Monitoring
  • Telemedicine
  • World
  • Forecast

Drivers and Their Impact Increased Prevalence of Obesity Presence of High Unmet Needs Low ## ## ## ## ## High Low High Impact on Key Customer Category Patients Low Low ## ## ## ## ## High Low Pharmacies High ## ## ## ## ## High Low High High Low ## ## ## ## ## High Low ## ## ##

  • Obesity
  • United States
  • Arena Pharmaceuticals, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc

PLoS One, ##(##), e##.

  • Obesity
  • United States
  • AstraZeneca PLC
  • NSTEMI group
  • The Medicines Company

The immune systems of these new-borns are more susceptible to diseases such as asthma, diabetes, obesity or cardiac diseases.

  • Obesity
  • United States
  • Enterome Bioscience SA
  • MicroBiome Therapeutics LLC
  • Seres Therapeutics, Inc.

GLP-## = glucagon-like peptide-##.

  • Obesity
  • United States
  • EnteroMedics Inc.
  • Novo Nordisk Group
  • VIVUS, Inc.

It is also developing new approaches to the treatment of asthma.

  • Insulin
  • Obesity
  • World
  • Product Initiative
  • Amylin Pharmaceuticals, Inc.
  • INV-88 - DRUG PROFILE
  • TYPE2 DIABETES - PIPELINE BY OPKO HEALTH INC, H1 2018

It is also developing new approaches to the treatment of asthma.

  • Biopharmaceutical
  • Obesity
  • North America
  • United States
  • Company

The clinical trials of its probiotic products for HIV, acute diverticulitis, rhinitis, asthma, and grass allergy are nearing completion.

  • Nutraceutical
  • Obesity
  • North America
  • United States
  • Yakult Honsha Co., Ltd.
  • TYPE 2 DIABETES - PIPELINE BY INSPYR THERAPEUTICS INC, H2 2017
  • INV-88 - DRUG PROFILE

Type 2 Diabetes - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes - Pipeline Review, H2 2017, provides an overview of the Type 2 Diabetes (Metabolic Disorders) pipeline landscape. Type 2 diabetes is a chronic...

  • Biopharmaceutical
  • Obesity
  • North America
  • United States
  • Company

It also performs clinical trials and tolerance assay studies in transplantation, autoimmune diseases, and allergy and asthma.

  • Obesity
  • Pharmaceutical
  • Therapy
  • United States
  • Novo Nordisk Group

Presented post approval study results at the American Thoracic Society International Conference that demonstrated the Alair™ Bronchial Thermoplasty System reduced complications, including severe asthma exacerbations and asthma-related hospitalizations, in adult patients with severe

  • Medical Device
  • Obesity
  • United States
  • Company
  • GI Dynamics

PRESENTED POST APPROVAL STUDY RESULTS AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE THAT DEMONSTRATED THE ALAIR™ BRONCHIAL THERMOPLASTY SYSTEM REDUCED COMPLICATIONS, INCLUDING SEVERE ASTHMA EXACERBATIONS AND ASTHMA-RELATED HOSPITALIZATIONS, IN ADULT PATIENTS WITH SEVERE

  • Clinical Trial
  • Mental Health
  • Obesity
  • Therapy
  • GlobalData's company

The company has expertise in the areas of cardiovascular, asthma, diabetology, pediatrics, central nervous system, gastro-intestinal, anti-infectives, NSAIDs, anti-TB and cephalosporins.

  • Musculoskeletal Disorder
  • Obesity
  • United States
  • Company
  • Product Initiative
  • TYPE 2 DIABETES - PIPELINE BY ZYDUS CADILA HEALTHCARE LIMITED, H2 2016
  • OBESITY - PIPELINE BY ORBIS BIOSCIENCES INC, H2 2016

Its pharmaceutical products comprise inhaled corticosteroid for asthma, osteoporosis drugs, anti-hyperuricemia agent, and others.

  • Biotechnology
  • Obesity
  • Type 2 Diabetes
  • Company
  • Product Initiative
  • Latest Clinical Trials News on Abdominal Obesity

About LIPO-## LIPO-## is an injectable formulation of salmeterol xinafoate, a well-known long-acting ß##-adrenergic receptor agonist used in several FDA-approved drugs, including ADVAIR for asthma.

  • Obesity
  • Pathology
  • World
  • Product Initiative
  • Neothetics, Inc.

According to the American Academy of Allergy, Asthma & Immunology (AAAAI), from 2011 to 2014, the prevalence rate of asthma was ##. ##% among all adults in the U. S.

  • Obesity
  • North America
  • United States
  • Market Size
  • Omada Health, Inc.
  • OPKO BIOLOGICS LTD
  • OBESITY - PIPELINE BY PROMETIC LIFE SCIENCES INC, H1 2018

It is also developing new approaches to the treatment of asthma.

  • Diabetes
  • Obesity
  • United States
  • Company
  • Product Initiative

We also see many clinical trials related to asthma, diabetes and cancer.

  • Healthcare
  • Obesity
  • Pharmaceutical
  • Therapy
  • Denmark

PIERRE AND MIQUELON SAINT KITTS AND NEVIS AMERICA NOT ELSEWHERE SPECIFIED ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ##

  • Diabetes
  • Insulin
  • Obesity
  • World
  • Market Size
  • OPKO BIOLOGICS LTD
  • INV-88 - DRUG PROFILE

It provides pipeline products which are under development for the treatment of asthma, stroke, obesity, dementia and Hepatitis C.

  • Diabetes
  • Obesity
  • Pharmaceutical
  • Therapy
  • Omeros Corporation

It is also developing new approaches to the treatment of asthma.

  • Chronic Disease
  • Obesity
  • United States
  • Product Initiative
  • Amarin Corporation plc

GPR##/ TDAG## has been linked to several types of cancer and to inflammatory disorders, such as asthma.

  • Obesity
  • Psychotic Disorder
  • Therapy
  • United States
  • Omeros Corporation

Nuvance was under development for the treatment of asthma.

  • Cancer
  • Obesity
  • Therapy
  • United States
  • Amgen Inc.

It was also under development for the treatment of asthma.

  • Monoclonal Antibody
  • Obesity
  • Research And Development
  • United States
  • Bristol-Myers Squibb Company

## ## ## United Kingdom ## ## ## ## ## ## ## ## ## Canada ## ## ## ## ## ## ## ## ## Japan ## ## ## ## ## ## ## ## ## Germany ## ## ## ## ## ## ## ## ## Italy ## ## ## ## ## ## ## ## ## France ## ## ## ## ## ##

  • Eating Disorder
  • Obesity
  • Therapy
  • World
  • Product Initiative

Obesity is likely to lead to diseases such as asthma, diabetes, and cardiovascular disorders at an earlier age, and is thus an issue of concern for governments.

  • Fitness
  • Obesity
  • Weight Loss
  • Market Size
  • Technogym S.p.A.